1. The Data and Safety Monitoring Board and Acquired immune deficiency syndrome (AIDS) clinical trials
2. Code of Federal Regulations. U.S. Government Printing Office, Washington, 2000.
3. Guideline for the ?Format and Content of the Clinical and Statistical Sections of New Drug Applications?. U.S. Department of Health and Human Services, Public Health Service, FDA, July 1988.
4. PMA/FDA Workshop. Clinical Trial Monitoring and Interim Analysis in the Pharmaceutical Industry, Sheraton Washington Hotel, Washington, D.C., February 24-25, 1992.
5. Data monitoring and interim analyses in the pharmaceutical industry: Ethical and logistical considerations